Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 188396-77-2, Paliroden [inn], Sr57667b, Palirodene, Palirodeno, Unii-17vj76l90t
Molecular Formula
C26H24F3N
Molecular Weight
407.5  g/mol
InChI Key
CNEWKIDCGDXBDE-UHFFFAOYSA-N
FDA UNII
17VJ76L90T

Paliroden is an orally active neurotrophic, non-peptidic compound that activates synthesis of endogenous neurotrophines. Studies show that use of paliroden increased the rate of formation of both neural progenitors and mature neurons. It is indicated for use in Alzheimer's Disease and Parkinsons.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[2-(4-phenylphenyl)ethyl]-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2H-pyridine
2.1.2 InChI
InChI=1S/C26H24F3N/c27-26(28,29)25-8-4-7-24(19-25)23-14-17-30(18-15-23)16-13-20-9-11-22(12-10-20)21-5-2-1-3-6-21/h1-12,14,19H,13,15-18H2
2.1.3 InChI Key
CNEWKIDCGDXBDE-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
17VJ76L90T
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 188396-77-2

2. Paliroden [inn]

3. Sr57667b

4. Palirodene

5. Palirodeno

6. Unii-17vj76l90t

7. 17vj76l90t

8. Sr5-7667b

9. 1-(2-(biphenyl-4-yl)ethyl)-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine

10. 1-(2-([1,1'-biphenyl]-4-yl)ethyl)-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine

11. Palirodenum

12. 1-(2-((1,1'-biphenyl)-4-yl)ethyl)-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine

13. 1-(2-{[1,1'-biphenyl]-4-yl}ethyl)-4-[3-(trifluoromethyl)phenyl]-1,2,3,6-tetrahydropyridine

14. 1-[2-([1,1'-biphenyl]-4-yl)ethyl]-4-[3-(trifluoromethyl)phenyl]-1,2,3,6-tetrahydropyridine

15. Refchem:169612

16. Sr57667 Base

17. 1-[2-(4-phenylphenyl)ethyl]-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2h-pyridine

18. Orb1706848

19. Schembl4587135

20. Chembl2107767

21. Schembl29375649

22. C26h24f3n

23. Dtxsid60870180

24. Cnewkidcgdxbde-uhfffaoysa-n

25. Nha39677

26. Ex-a12275

27. Mfcd30747895

28. Akos040742362

29. Cs-6710

30. Db05454

31. Da-56559

32. Ms-26996

33. Hy-101580

34. Ns00072159

35. Q27251945

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 407.5 g/mol
Molecular Formula C26H24F3N
XLogP36.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area3.2
Heavy Atom Count30
Formal Charge0
Complexity555
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in Alzheimer's disease and Parkinson's disease.


5 Pharmacology and Biochemistry
5.1 Mechanism of Action

SR 57667 may be an irreversible MAOB inhibitor.